comparing the performance of blood-based amyloid and tau assays
Published 1 year ago • 69 plays • Length 5:05Download video MP4
Download video MP3
Similar videos
-
6:37
blood-based biomarkers as surrogates of amyloid burden in preclinical alzheimer's disease
-
2:25
comparing the performance of novel biomarkers across the spectrum of alzheimer’s disease
-
1:56
blood p-tau in symptomatic and non-symptomatic ad patients
-
3:09
head-to-head comparison of p-tau species for alzheimer’s disease detection in a real-world cohort
-
0:56
the advantage of blood-based screening for alzheimer’s disease
-
4:33
plasma p-tau as a biomarker for cerebral amyloid angiopathy diagnosis
-
32:51
update on blood tests for alzheimer’s disease
-
5:31
the spreading pathways of tau and amyloid
-
1:16
can we predict the onset of alzheimer's disease using blood tests?
-
1:58
the value of plasma p-tau181 as a screening and diagnostic tool for alzheimer’s disease
-
2:31
diagnosing alzheimer’s disease using blood-based biomarkers
-
5:21
clinical robustness of csf ptau/aβ42 ratio for alzheimer’s disease diagnosis
-
4:50
blood-based biomarkers in alzheimer disease
-
6:04
advancing biomarker development: looking beyond amyloid and tau with dr. richard isaacson
-
48:59
blood tests for brain health in alzheimer’s disease and related dementias
-
0:56
blood-based biomarkers for treatment monitoring in alzheimer’s disease
-
2:03
investigating the relationship of tau and amyloid in alzheimer’s disease
-
13:09
new blood test for alzheimer’s disease
-
3:47
beta amyloid and tau proteins (transglutaminase substrates) osmosis & neuroscientifically challenged